These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
68 related items for PubMed ID: 9259955
1. Chromosome aberrations after radiotherapy in patients treated for non Hodgkin's lymphoma. Mahé MA, André MJ, Moyon E, Le Mevel A, Soubeyran P, Hamidou M, Milpied N, Bourdin S, Cuillière JC, Chatal JF. Ann Genet; 1997; 40(2):92-8. PubMed ID: 9259955 [Abstract] [Full Text] [Related]
7. Time-course of radiation-induced chromosomal aberrations in tumor patients after radiotherapy. Müller I, Geinitz H, Braselmann H, Baumgartner A, Fasan A, Thamm R, Molls M, Meineke V, Zitzelsberger H. Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1214-20. PubMed ID: 16253775 [Abstract] [Full Text] [Related]
8. Analysis of chromosome aberrations by FISH and Giemsa assays in lymphocytes of cancer patients undergoing whole-body irradiation: comparison of in vivo and in vitro irradiation. Vorobtsova I, Darroudi F, Semyonov A, Kanayeva A, Timofeyeva N, Yakovleva T, Zharinov G, Natarajan AT. Int J Radiat Biol; 2001 Nov 15; 77(11):1123-31. PubMed ID: 11683983 [Abstract] [Full Text] [Related]
9. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP. Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1173-80. PubMed ID: 19386423 [Abstract] [Full Text] [Related]
10. Unstable chromosome aberrations in peripheral blood lymphocytes from patients with cervical uterine cancer following radiotherapy. Magnata SP, Serafim I, Netto J, Gomes P, Netto AM, Amaral A. Cell Mol Biol (Noisy-le-grand); 2002 Nov 15; 48(7):809-11. PubMed ID: 12619980 [Abstract] [Full Text] [Related]
11. Cytogenetic monitoring of pesticide sprayers. Joksić G, Vidaković A, Spasojević-Tisma V. Environ Res; 1997 Nov 15; 75(2):113-8. PubMed ID: 9417841 [Abstract] [Full Text] [Related]
12. Persistence of chromosome aberrations in peripheral lymphocytes from Hodgkin's lymphoma remission patients. Ryabchenko N, Nasonova V, Antoschina M, Fesenko E, Kondrashova T, Ivanova T, Pavlov V, Ryabikhina N, Terekhova A. Int J Radiat Biol; 2003 Apr 15; 79(4):251-7. PubMed ID: 12775449 [Abstract] [Full Text] [Related]
13. Biological estimation of dose in hemi-body irradiation of cancer patients by cytogenetic analysis. Senthamizhchelvan S, Pant GS, Rath GK, Julka PK, Nair O, Prabhakar R, Malhotra A. Health Phys; 2008 Feb 15; 94(2):112-7. PubMed ID: 18188045 [Abstract] [Full Text] [Related]
14. Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation. Liauw SL, Yeh AM, Morris CG, Olivier KR, Mendenhall NP. Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1440-5. PubMed ID: 16997504 [Abstract] [Full Text] [Related]
15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383 [Abstract] [Full Text] [Related]
16. [The mechanisms of adaptive response. Estimation of capacity of human blood lymphocytes to radiation adaptive response using different criteria]. Serebrianyĭ AM, Antoshchina MM, Aleshchenko AV, Riabchenko NI, Pelevina II. Tsitologiia; 2008 Dec 01; 50(5):462-6. PubMed ID: 18683593 [Abstract] [Full Text] [Related]
17. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease. Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):208-18. PubMed ID: 15093918 [Abstract] [Full Text] [Related]
18. [The cytogenetic reaction of the lymphocytes to in-vitro irradiation in children born to patients after antitumor radio- and chemotherapy]. Vorobtsova IE, Vorob'eva MV, Korytova LI, Shust VF. Tsitologiia; 1995 May 01; 37(5-6):449-57. PubMed ID: 8658974 [Abstract] [Full Text] [Related]
19. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA, Roach M, Bosch W, Cox JD. Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):706-13. PubMed ID: 15936549 [Abstract] [Full Text] [Related]
20. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C. Haematologica; 1998 Sep 01; 83(9):812-23. PubMed ID: 9825578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]